The STARFISH Trial: A randomised controlled trial of STeroid Administration Routes For Idiopathic Sudden sensorineural Hearing loss
Who we're recruiting
Adults in the UK aged 18 years or over with a diagnosis of new-onset Idiopathic Sudden sensorineural Hearing loss (ISSNHL), who meet eligibility criteria.
What is involved
We aim to find out which route (oral, intratympanic, or combined) of steroid treatment works best in improving hearing for patients with ISSNHL. Read more: www.entintegrate.co.uk/starfish
How to participate
Refer adults with suspected ISSNHL to secondary care as per NICE guidelines and highlight their potential eligibility for participation in the trial. (To confirm if your local ENT department is involved in the trial/ for more information, email STARFISH@trials.bham.ac.uk)
End date
May 2025